Publications
- Regorafenib for metastatic colorectal cancer: An analysis of a registry-based cohort of 555 patients2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Safety and effectiveness of aflibercept + fluorouracil, leucovorin, and irinotecan (FOLFIRI) for the treatment of patients with metastatic colorectal cancer (mCRC) in current clinical practice: OZONE study2020 | Publication without faculty affiliation
- Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry2017 | First Faculty of Medicine
- Metastatic colorectal cancer2017 | Publication without faculty affiliation
- Bevacizumab with chemotherapy in patients with KRAS wild-type metastatic colorectal cancer: Czech registry data2015 | Publication without faculty affiliation
- Regorafenib in the treatment of advanced gastrointestinal stromal tumour +12015 | Publication without faculty affiliation
- Aflibercept in the treatment of metastatic colorectal cancer2014 | Second Faculty of Medicine
- Regorafenib monotherapy in pretreated metastatic colorectal cancer (CORRECT): an international, multicenter, randomized, placebo-controlled clinical trial Phase 32013 | Second Faculty of Medicine
- Irinotecan in Combination with 5-fluorouracil and Leucovorin in the Treatment of Metastatic Colorectal Cancer2005 | Publication without faculty affiliation
- Klinická onkologie2023 | Second Faculty of Medicine, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen
Loading network view...